Financing - May 31, 2022
Capitainer raises 34 million SEK
Capitainer has closed a share issue to capitalize on growing interest in home-sampling with its new qDBS dried blood spot testing system. The investment round, led by Sciety, brought in both existing and new industry specialist investors and several board members and the CEO. “Once again we are delighted to have secured such strong support […]
Biotech Business - February 15, 2022
Capitainer and Attana sign collaboration agreement
The two companies have signed an agreement with the goal of offering broader and more patient-centric blood sampling solutions for the Attana AVATM system starting with COVID-19 immune profiling. Since November 2021, Attana has been performing comparative studies of finger stick capillary blood samples simultaneously collected by both test tubes and Capitainer qDBS cards (quantitative […]
In a new job - January 29, 2022
Capitainer appoints representative for North Americas
Capitainer has announced that Donald H. Chace has been appointed as Capitainer representative for North Americas. Bringing experience covering Neonatology, Clinical Chemistry, Newborn Screening, Mass Spectrometry and Forensic Science, he joins the team as Capitainer looks to penetrate the US market with their qDBS dried blood sampling technology, it states. “We are delighted to welcome […]
COVID-19 - May 5, 2021
Capitainer’s COVID-19 test suitable for clinical population testing
Capitainer has announced that its home self-sampling kit proves 97% effective for clinical mass-testing of COVID-19 vaccine efficacy. In a recent Swedish large scale population study, 97% of the samples self-collected and returned to the lab by private individuals met the official quality standard for accurate analysis resulting in clinical diagnosis, states the company in […]
In a new job - April 13, 2021
Capitainer appoints Business Development Manager
Capitainer has announced that Mikael Ström (PhD) has been appointed as Business Development Manager. He joins the team, bringing valuable large scale hospital laboratory expertise, as Capitainer continues to add new applications for their proprietary qDBS dried blood sampling technology, states the company in a press release. Mikael Ström Prior to joining Capitainer, Mikael Ström […]
COVID-19 - February 22, 2021
Capitainer’s system employed in COVID-19 study in the US
The company’s qDBS dried blood spot system for home sample collection is being used in a nation-wide randomized clinical trial on the role of Vitamin D in COVID-19 run by Harvard Medical School. Participants in the study, who are recruited throughout the U.S., aged >18 years, and recently diagnosed with COVID-19, are mailed the qDBS […]
